SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer
NCT01583361
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
772
Enrollment
OTHER
Sponsor class
Conditions
Gastric Adenocarcinoma
Interventions
DRUG:
Oxaliplatin+S-1
DRUG:
Adjuvant Oxaliplatin/S-1（SOX）
Sponsor
Lin Chen